Slone Partners Places Will Geist as Chief Operating Officer at Quanterix

Geist brings operational experience to Quanterix as company scales to support rapid growth

Slone Partners, a nationwide executive search firm for life science, biotechnology, and diagnostics companies, has announced the placement of Will Geist as Chief Operating Officer (COO) at Quanterix Corporation. In his new role, Geist will build on Quanterix’ track record of strong execution as the company expands globally and continues to disrupt pharmaceutical development and diagnostics research.

Geist brings more than 25 years of experience to Quanterix, most recently serving as Vice President and General Manager for two of Thermo Fisher Scientific’s largest business units – Protein and Cell Analysis (PCA), and qPCR. He also served a key leadership role in Thermo Fisher Scientific’s Biosciences Division COVID-19 Task Force. Prior to joining Thermo Fisher Scientific, Geist held several other top leadership titles, including Vice President of Sales, Marketing and Business Development at QIAGEN’s Quanta BioSciences.

Recommended AI News: Teradata Extends Hybrid Multi-Cloud Capabilities as Customers Move More Workloads to the Cloud

“Will Geist is an extraordinarily talented and accomplished executive with an impressive track record of success in operations, sales, marketing, and business development leadership roles,” said Slone Partners CEO Leslie Loveless. “He will be a welcome addition to the very strong Quanterix executive team at an important time in the company’s evolution.”

Recommended AI News: Uberflip Deploys Matillion ETL for Snowflake

“Quanterix is experiencing strong momentum across numerous digital biomarker platforms supporting drug development and non-invasive, early disease diagnostics research,” said Kevin Hrusovsky, Chairman, Chief Executive Officer and President, Quanterix. “We are fortunate to attract Will into Quanterix at this important time given his wealth of operating experience and track record for growing revenue and profitability, both commercially and operationally.”

“I am very excited to join Quanterix during this phase of growth and expansion,” said Geist. “I have long admired the company’s mission and welcome the opportunity to further operationalize and scale the innovation that Quanterix continues to achieve as part of its vision for precision health.”

Recommended AI News: Hot Startups : Latest News And Updates On Daily Roundup